2009 – 9th ESNI COURSE | Istanbul (Turkey) | 1-4 September
I Day
Neuroscience and neurobiology: basic aspects
- The host defense of Drosophila melanogaster (Dominique Ferrandon)
- Immune response in plants (Saskia van Wees)
- The inflammasome: a new entry (Stefan Drexler)
- Autophagy in autoimmunity (Francesco Cecconi)
- The immunomodulatory role of neural stem cells (Stefano Pluchino)
- Astrocytes, inflammation and neurodegeneration (Trevor Owens)
- From Th1 to Th17: relevance for CNS autoimmunity (Burkhard Becher)
- The role of infection in CNS autoimmunity (Matthias Von Herrath)
II Day
Basic and clinical aspects of neuroinflammation
- Genetics of animal models of CNS inflammation (Maja Jagodic)
- Innate immunity in the progression of inflammatory neurodegen (Christine Dijkstra)
- T cells in CNS tissue damage (Roland Liblau)
- Neuronal control of brain inflammation (Lesley Probert)
- Evolving neuropathological characterization of multiple sclero (Hans Lassmann)
- Ion channels as therapeutic targets of neurodegeneration n (Ken Smith)
- Dendritic cells and antigen presentation in the CNS during autoimmune disease. (Adi Vaknin-Dembinsky)
- B cells in multiple sclerosis pathogenesis (Francesca Aloisi)
III Day
Basic and clinical aspects of immune-mediated neuromuscular disorders
- Mouse models of human neuromuscular disorders in vivo and ex vivo: a behavioural and physiological perspective (Jaap Plomp)
- How to study the node of Ranvier: a cell biologist’s perspective (Elior Peles)
- Acquired peripheral neuropathies; from inflammation to demyelination (Angelo Quattrini )
- Inflammatory components to genetic neuropathies: seeing is believing. (Rudolf Martini)
- What’s new and clinically useful in the anti-nerve antibody field? (Bart Jacobs )
- Establishing novel diagnostic assays in a clinical neuroimmunology laboratory setting (Angela Vincent)
- Clinical research in motor nerve terminal and neuromuscular junction disorders (Jan Verschuuren)
- Developments in the scientific and clinical understanding of inflammatory myopathies (Ingrid Lundberg)
IV Day
Pathogenesis and therapy of multiple sclerosis
- Understanding multiple sclerosis pathogenesis: what animal models have taught us? (Chris Linington)
- Myelin repair in CNS: Role for guidance molecules (Catherine Lubetzki)
- B cell immunology and multiple sclerosis: implications for treatment and data from clinical trials (Amit Bar-Or)
- What can we learn from treating multiple sclerosis? (Orhan Aktas)
- Scientific thinking; science education and ethics(Emin Kansu)
- Potential new players on multiple sclerosis therapy: an introductory overview (Rana Karabudak)
- Lysophospholipids as mediators of immunity (Orhan Aktas)
- Oral fingolimod and teriflunomide: mechanism of action, pre-clinical and clinical data in multiple sclerosis (Gulsen Akman-Demir)
- Rescue treatments: urgent treatments need for transitional stage multiple sclerosis (Orhun Kantarci)